A 360° view on tech world
When Charles Onu’s cousin was born with birth asphyxia and later developed a hearing condition, the seed for Ubenwa, an audio biometric company geared at identifying neurological disorders in infants, was also planted. Onu, CEO and co-founder, said he hopes Ubenwa will change the way physicians provide care to infants. “We’re trying to bring the […]
Read more
Nucleus Genomics, a genetic testing company focused on calculating a patient’s risk of certain diseases, is adding $14 million to their initial seed funding round. With this round the company has raised, in total, $17.5 million. This “seed plus” funding round was led by Alexis Ohanian’s 776. Ohanian is joining investors like Founders Fund, Adrian […]
Read more
In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio’s molecular machinery could let a hundred molecules be tested simultaneously in a single […]
Read more
U.S. Energy Secretary Jennifer Granholm said she is still “hopeful, positive and in fact bullish” that Congress can agree on “a significant push into clean energy.”
Read more
Many of us take prescription medication with little to no understanding of just how long it takes — or how much it costs — to get that drug to market. Conducting clinical trials of a given medication usually takes years and lots of money. It is estimated that in 2019, the pharmaceutical industry spent $83 […]
Read more
The technology is not “new,” but what has industry followers so excited is the potential for better-quality, more-cost-effective proteins compared to animal-based counterparts.
Read more
The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. One approach that seemed unthinkable just a few years ago is simulating the complicated interplays of two interlocking molecules — but that’s exactly what drug designers need to know about, and exactly what Charm Therapeutics aims to do with its […]
Read more
The company’s first product, UnReal Milk, is “real” whole milk created using mammalian cell culture technology.
Read more
Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain investors are continuing to bet on emerging biotechnologies — which often take longer to prove profitability compared to other verticals — at a time venture […]
Read more
Biologists and other scientists are confronted these days with a deep sea of data and a bewildering panoply of tools to apply to it — many of which require a specialist to operate. Hiring one is a challenge and farming out the work may take months … but LatchBio offers an option that can have […]
Read more